Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccines

• Main Authors: Katia J Bruxvoort (Author), Lina S Sy (Author), Jeff Slezak (Author), Bradley K Ackerson (Author), Lei Qian (Author), Sijia Qiu (Author), Zendi Solano (Author), Kristi Reynolds (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

HepB-CpG is a licensed adjuvanted two-dose hepatitis B vaccine for adults, with limited data on exposure during pregnancy. We assessed the risk of pregnancy outcomes among individuals who received HepB-CpG or the 3-dose HepB-alum vaccine ≤28 d prior to conception or during pregnancy at Kaiser Perman...